A teen receives her Pfizer Covid-19 booster at a CVS pharmacy in New York City on Jan. twentieth, 2022.
Adam Jeffery | CNBC
CVS Health stated Wednesday that demand for at-home Covid checks and booster photographs lifted total retailer gross sales, serving to the corporate high expectations for fourth-quarter earnings.
Shares of the pharmacy chain and well being insurer fell greater than 2% in premarket buying and selling.
Here’s what the corporate reported for the three-month interval ended Dec. 31, in contrast with what analysts had been anticipating, primarily based on a survey of analysts by Refinitiv:
Earnings per share: $1.98 adjusted vs. $1.93 expectedRevenue: $76.60 billion vs. $75.67 billion anticipated
CVS reported fiscal fourth-quarter internet revenue of $1.31 billion, or 99 cents per share, up from $973 million, or 74 cents per share, a yr earlier.
The firm stated its internet revenue from persevering with operations was 98 cents. But it earned $1.98 per share, after changes, which was greater than the $1.93 per share anticipated by analysts surveyed by Refinitiv.
Total income for the interval rose to $76.60 billion from $69.55 billion a yr earlier, exceeding expectations of $75.67 billion.
Shares of CVS are up 51% over the previous 12 months and touched a 52-week excessive on Tuesday. Shares closed Tuesday at $110.83, up 1.3%. The firm’s market worth is $146.30 billion.
